- Home
- AGL vs ABCL Comparison
AGL vs ABCL Comparison
Compare AGL & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGL
- ABCL
- Stock Information
- Founded
- AGL 2016
- ABCL 2012
- Country
- AGL United States
- ABCL Canada
- Employees
- AGL N/A
- ABCL N/A
- Industry
- AGL Managed Health Care
- ABCL Biotechnology: Pharmaceutical Preparations
- Sector
- AGL Health Care
- ABCL Health Care
- Exchange
- AGL Nasdaq
- ABCL Nasdaq
- Market Cap
- AGL 952.1M
- ABCL 1.1B
- IPO Year
- AGL 2021
- ABCL 2020
- Fundamental
- Price
- AGL $1.33
- ABCL $4.39
- Analyst Decision
- AGL Hold
- ABCL Strong Buy
- Analyst Count
- AGL 20
- ABCL 5
- Target Price
- AGL $3.09
- ABCL $8.00
- AVG Volume (30 Days)
- AGL 22.2M
- ABCL 5.5M
- Earning Date
- AGL 08-04-2025
- ABCL 08-07-2025
- Dividend Yield
- AGL N/A
- ABCL N/A
- EPS Growth
- AGL N/A
- ABCL N/A
- EPS
- AGL N/A
- ABCL N/A
- Revenue
- AGL $5,901,182,000.00
- ABCL $32,875,999.00
- Revenue This Year
- AGL N/A
- ABCL N/A
- Revenue Next Year
- AGL $10.13
- ABCL $71.11
- P/E Ratio
- AGL N/A
- ABCL N/A
- Revenue Growth
- AGL 11.76
- ABCL N/A
- 52 Week Low
- AGL $0.71
- ABCL $1.89
- 52 Week High
- AGL $6.08
- ABCL $5.82
- Technical
- Relative Strength Index (RSI)
- AGL 43.73
- ABCL 51.44
- Support Level
- AGL $1.17
- ABCL $4.01
- Resistance Level
- AGL $1.28
- ABCL $4.81
- Average True Range (ATR)
- AGL 0.14
- ABCL 0.36
- MACD
- AGL 0.06
- ABCL -0.05
- Stochastic Oscillator
- AGL 96.09
- ABCL 42.59
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.